CTS Capital
Asia, Liaoning, China, Chaoyang'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
CTS Capital is a healthcare-focused fund investing in the top players of the medical vertical sector.
Investor Profile
CTS Capital has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in China, Hong Kong.
- Strong thematic focus on Health Care, Medical, Biotechnology.
Stage Focus
- Series B (25%)
- Series Unknown (25%)
- Series A (25%)
- Series C (25%)
Country Focus
- China (75%)
- Hong Kong (25%)
Industry Focus
- Health Care
- Medical
- Biotechnology
- Clinical Trials
- Precision Medicine
- Medical Device
- Oncology
- Biopharma
- Life Science
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does CTS Capital frequently co-invest with?
What are some of recent deals done by CTS Capital?
Find More Investors Like CTS Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








